Single-cell Omics Market Introduction and Overview
According to SPER Market Research, the Global Single-cell Omics Market is estimated to reach USD 18.67 billion by 2033 with a CAGR of 20.42%.
The report includes an in-depth analysis of the Global Single-cell Omics market, including market size and trends, product mix, distribution channels, and supplier analysis. The Single-cell omics is an emerging area of study that looks at individual cells to acquire a better knowledge of cellular processes, heterogeneity, and disease pathology. Single cell genome-wide techniques offer a valuable chance to test many substances with high precision, such as DNA, RNA, protein, and chromatin. We may develop a multi-omics profile for the same cell using these several single cell omics profiling methodologies as building pieces. High-throughput technology development
- BioExcel Diagnostic tools and Takara Bio USA, Inc., innovation life science reagent and device businesses, are developing and validating a current high and comprehensive technique for diagnosing infectious diseases based on syndromic markers. Takara Bio USA, Inc. is a wholly owned subsidiary of Takara Bio Inc.
- QIAGEN and Neuron23 Inc., an initial biotechnology company dedicated to developing precision medications for genetic neurological and immunological diseases, announced the signing of an agreement to create a partner screening for Neuron23's brain penetrant, blocker for Parkinson's disease.
Market Opportunities and Challenges
Opportunities: Single-cell omics can aid in the identification of biomarkers for illness diagnosis, prognosis, and treatment response. This could lead to the creation of new diagnostic tests and medicines. Single-cell omics can assist uncover new pharmacological targets and pathways, as well as analyze medication efficacy and toxicity. This could lead to the development of more effective and safer medications. Single-cell omics can assist improve crop productivity and quality, as well as food safety and traceability.
Challenges: The common difficulty that makes this market hard is sample preparation and cell reproducibility. High infrastructure costs - because technology, databases, and equipment are all highly expensive to purchase. As a result, it presents a significant barrier to entry for newly formed businesses seeking to compete with market giants. The cost of equipment and technology can only be justified if the professionals who will use them are available, which is another significant hurdle in the Single cell omics market. Clinical regulations in the application of single cell omics are extremely important and can complicate the entire procedure.
Market Competitive Landscape
The market for Single-cell Omics is extremely consolidated. 10X Genomics, Inc, 1CellBio, BGI Genomics Co. Ltd, Bio-Rad Laboratories, Inc, Celsee, Inc, Fluxion Biosciences, GE LifeSciences, Illumina, Inc, Mission Bio, and QIAGEN N.V. Some of the market key players in global Single-cell Omics market.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | Product, By Application, By End User
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
|
| Companies Covered | 10X Genomics, Inc, 1CellBio, BGI Genomics Co. Ltd, Bio-Rad Laboratories, Inc, Celsee, Inc, Fluxion Biosciences, GE LifeSciences, Illumina, Inc, Mission Bio, and QIAGEN N.V.
|
COVID-19 Impact on Global Single-cell Omics Market
The development of the COVID-19 pandemic boosted the single-cell omics market. As the globe faced a historic health crisis, researchers and scientists resorted to single-cell omics technologies as effective tools for unraveling the complexity of the SARS-CoV-2 virus and its consequences on the human body. These technologies were critical in assessing immune responses, finding biomarkers, and evaluating illness causes, supplementing market trends. Furthermore, single-cell omics aided in the rapid creation of targeted antiviral therapies and vaccines by offering insights into the virus's complicated interactions with host cells. Furthermore, the increasing focus and financing for COVID-19 research sparked innovation in single-cell omics platforms, making them more accessible, efficient, and scalable.
Key Target Audience:
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutions
- Clinical Laboratories and Diagnostics Companies
- Biomedical Researchers
- Government and Regulatory Agencies
- Investors and Venture Capital Firms
- Healthcare Providers
- Genomic Service Providers
- Bioinformatics and Data Analysis Providers
Our in-depth analysis of the Single-cell Omics Market includes the following segments:
|
By Product:
|
Single Cell Genomics
Single Cell Proteomics
Single Cell Transcriptomics
Single Cell Metabolomics
|
|
By Application:
|
Oncology
Cell Biology
Neurology
Immunology
|
|
By End Use:
|
Academic & Research Laboratories
Biotechnology & Pharmaceutical Companies
Hospitals & Diagnostic Laboratories
|
Key Topics Covered in the Report:
- Global Single-cell Omics Market Size (FY’2023-FY’2033)
- Overview of Global Single-cell Omics Market
- Segmentation of Global Single-cell Omics Market By Product (Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics)
- Segmentation of Global Single-cell Omics Market By Application (Oncology, Cell Biology, Neurology, Immunology)
- Segmentation of Global Single-cell Omics Market By End User (Academic & Research Laboratories, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Others)
- Statistical Snap of Global Single-cell Omics Market
- Expansion Analysis of Global Single-cell Omics Market
- Problems and Obstacles in Global Single-cell Omics Market
- Competitive Landscape in the Global Single-cell Omics Market
- Impact of COVID-19 and Demonetization on Global Single-cell Omics Market
- Details on Current Investment in Global Single-cell Omics Market
- Competitive Analysis of Global Single-cell Omics Market
- Prominent Players in the Global Single-cell Omics Market
- SWOT Analysis of Global Single-cell Omics Market
- Global Single-cell Omics Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Single-cell Omics Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Single-cell Omics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Single-cell Omics Market
7. Global Single-cell Omics Market, By Product (USD Million)
7.1. Global Single-cell Omics Market Value Share and Forecast, By Product, 2023-2033
7.2. Single Cell Genomics
7.3. Single Cell Proteomics
7.4. Single Cell Transcriptomics
7.5. Single Cell Metabolomics
8. Global Single-cell Omics Market , By Application (USD Million)
8.1. Global Single-cell Omics Market Value Share and Forecast, By Application, 2023-2033
8.2. Oncology
8.3. Cell Biology
8.4. Neurology
8.5. Immunology
8.6. Others
9. Global Single-cell Omics Market , By End Use (USD Million)
9.1. Global Single-cell Omics Market Value Share and Forecast, By End Use, 2023-2033
9.2. Academic & Research Laboratories
9.3. Biotechnology & Pharmaceutical Companies
9.4. Hospitals & Diagnostic Laboratories
9.5. Others
10. Global Single-cell Omics Market Forecast, 2019-2033 (USD Million)
10.1. Global Single-cell Omics Market Size and Market Share
11. Global Single-cell Omics Market, By Product, 2019-2033 (USD Million)
11.1. Global Single-cell Omics Market Size and Market Share By Product (2019-2026)
11.2. Global Single-cell Omics Market Size and Market Share By Product (2027-2033)
12. Global Single-cell Omics Market, By Application, 2019-2033 (USD Million)
12.1. Global Single-cell Omics Market Size and Market Share By Application (2019-2026)
12.2. Global Single-cell Omics Market Size and Market Share By Application (2027-2033)
13. Global Single-cell Omics Market, By End User, 2019-2033 (USD Million)
13.1. Global Single-cell Omics Market Size and Market Share By End User (2019-2026)
13.2. Global Single-cell Omics Market Size and Market Share By End User (2027-2033)
14. Global Single-cell Omics Market, By Region, 2019-2033 (USD Million)
14.1. Global Single-cell Omics Market Size and Market Share By Region (2019-2026)
14.2. Global Single-cell Omics Market Size and Market Share By Region (2027-2033)
14.3. Asia-Pacific
14.3.1. Australia
14.3.2. China
14.3.3. India
14.3.4. Japan
14.3.5. South Korea
14.3.6. Rest of Asia-Pacific
14.4. Europe
14.4.1. France
14.4.2. Germany
14.4.3. Italy
14.4.4. Spain
14.4.5. United Kingdom
14.4.6. Rest of Europe
14.5. Middle East and Africa
14.5.1. Kingdom of Saudi Arabia
14.5.2. United Arab Emirates
14.5.3. Rest of Middle East & Africa
14.6. North America
14.6.1. Canada
14.6.2. Mexico
14.6.3. United States
14.7. Latin America
14.7.1. Argentina
14.7.2. Brazil
14.7.3. Rest of Latin America
15. Company Profile
15.1. 10X Genomics, Inc
15.1.1. Company details
15.1.2. Financial outlook
15.1.3. Product summary
15.1.4. Recent developments
15.2. 1CellBio
15.2.1. Company details
15.2.2. Financial outlook
15.2.3. Product summary
15.2.4. Recent developments
15.3. BGI Genomics Co. Ltd
15.3.1. Company details
15.3.2. Financial outlook
15.3.3. Product summary
15.3.4. Recent developments
15.4. Bio-Rad Laboratories, Inc
15.4.1. Company details
15.4.2. Financial outlook
15.4.3. Product summary
15.4.4. Recent developments
15.5. Celsee, Inc
15.5.1. Company details
15.5.2. Financial outlook
15.5.3. Product summary
15.5.4. Recent developments
15.6. Fluxion Biosciences
15.6.1. Company details
15.6.2. Financial outlook
15.6.3. Product summary
15.6.4. Recent developments
15.7. GE LifeSciences
15.7.1. Company details
15.7.2. Financial outlook
15.7.3. Product summary
15.7.4. Recent developments
15.8. Illumina, Inc
15.8.1. Company details
15.8.2. Financial outlook
15.8.3. Product summary
15.8.4. Recent developments
15.9. Mission Bio
15.9.1. Company details
15.9.2. Financial outlook
15.9.3. Product summary
15.9.4. Recent developments
15.10. QIAGEN N.V
15.10.1. Company details
15.10.2. Financial outlook
15.10.3. Product summary
15.10.4. Recent developments
15.11. Takara Bio
15.11.1. Company details
15.11.2. Financial outlook
15.11.3. Product summary
15.11.4. Recent developments
15.12. Others
16. List of Abbreviations
17. Reference Links
18. Conclusion
19. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
